Aclaris Therapeutics, Inc. (ACRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Impact · against what's priced in

The presentation at the Bank of America Global Healthcare Conference provides general visibility for Aclaris Therapeutics but contains no material updates to clinical or financial catalysts. The impact on the stock price is negligible as conference appearances are standard corporate activity.

Scored by the NIS engine · methodology.

• biotech▲12%
• pharmaceuticals